These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30131297)

  • 1. Eradication of persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis.
    Dezube R; Jennings MT; Rykiel M; Diener-West M; Boyle MP; Chmiel JF; Dasenbrook EC
    J Cyst Fibros; 2019 May; 18(3):357-363. PubMed ID: 30131297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eradication strategy for persistent methicillin-resistant Staphylococcus aureus infection in individuals with cystic fibrosis--the PMEP trial: study protocol for a randomized controlled trial.
    Jennings MT; Boyle MP; Weaver D; Callahan KA; Dasenbrook EC
    Trials; 2014 Jun; 15():223. PubMed ID: 24925006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.
    Lo DK; Muhlebach MS; Smyth AR
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009650. PubMed ID: 30030966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.
    Lo DK; Hurley MN; Muhlebach MS; Smyth AR
    Cochrane Database Syst Rev; 2013 Feb; (2):CD009650. PubMed ID: 23450608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eradication of methicillin resistant Staphylococcus aureus detected for the first time in cystic fibrosis: A single center observational study.
    Kappler M; Nagel F; Feilcke M; Kröner C; Pawlita I; Naehrig S; Ripper J; Hengst M; von Both U; Forstner M; Hector A; Griese M
    Pediatr Pulmonol; 2016 Oct; 51(10):1010-1019. PubMed ID: 27378061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful eradication of newly acquired MRSA in six of seven patients with cystic fibrosis applying a short-term local and systemic antibiotic scheme.
    Kiefer A; Bogdan C; Melichar VO
    BMC Pulm Med; 2018 Jan; 18(1):20. PubMed ID: 29370836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic management of methicillin-resistant Staphylococcus aureus--associated acute pulmonary exacerbations in cystic fibrosis.
    Fusco NM; Toussaint KA; Prescott WA
    Ann Pharmacother; 2015 Apr; 49(4):458-68. PubMed ID: 25583881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of a methicillin-resistant Staphylococcus aureus (MRSA) eradication protocol in pediatric cystic fibrosis (CF) patients.
    Belarski E; Pettit R
    Pediatr Pulmonol; 2020 Mar; 55(3):654-659. PubMed ID: 31899860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I, Dose-Escalating Study of the Safety and Pharmacokinetics of Inhaled Dry-Powder Vancomycin (AeroVanc) in Volunteers and Patients with Cystic Fibrosis: a New Approach to Therapy for Methicillin-Resistant Staphylococcus aureus.
    Waterer G; Lord J; Hofmann T; Jouhikainen T
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31964790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic Tolerance and Treatment Outcomes in Cystic Fibrosis Methicillin-Resistant Staphylococcus aureus Infections.
    Lu KY; Wagner NJ; Velez AZ; Ceppe A; Conlon BP; Muhlebach MS
    Microbiol Spectr; 2023 Feb; 11(1):e0406122. PubMed ID: 36519944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients. An observational prospective cohort study of 11 patients.
    Vanderhelst E; De Wachter E; Willekens J; Piérard D; Vincken W; Malfroot A
    J Cyst Fibros; 2013 Dec; 12(6):662-6. PubMed ID: 23706641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review: Staphylococcus aureus and MRSA in cystic fibrosis.
    Goss CH; Muhlebach MS
    J Cyst Fibros; 2011 Sep; 10(5):298-306. PubMed ID: 21719362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.
    Lo DK; Hurley MN; Muhlebach MS; Smyth AR
    Cochrane Database Syst Rev; 2015 Feb; (2):CD009650. PubMed ID: 25927091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methicillin-resistant Staphylococcus aureus in children with cystic fibrosis: An eradication protocol.
    Solís A; Brown D; Hughes J; Van Saene HK; Heaf DP
    Pediatr Pulmonol; 2003 Sep; 36(3):189-95. PubMed ID: 12910579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis.
    Jennings MT; Dasenbrook EC; Lechtzin N; Boyle MP; Merlo CA
    J Cyst Fibros; 2017 Nov; 16(6):681-686. PubMed ID: 28446387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of telavancin in adolescent patients with cystic fibrosis and prior intolerance to vancomycin: A case series.
    Bernstein AT; Leigh MW; Goralski JL; Esther CR; McKinzie CJ
    J Cyst Fibros; 2018 Nov; 17(6):e48-e50. PubMed ID: 30170755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter Observational Study on Factors and Outcomes Associated with Various Methicillin-Resistant Staphylococcus aureus Types in Children with Cystic Fibrosis.
    Muhlebach MS; Heltshe SL; Popowitch EB; Miller MB; Thompson V; Kloster M; Ferkol T; Hoover WC; Schechter MS; Saiman L;
    Ann Am Thorac Soc; 2015 Jun; 12(6):864-71. PubMed ID: 25745825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient segregation and aggressive antibiotic eradication therapy can control methicillin-resistant Staphylococcus aureus at large cystic fibrosis centres.
    Doe SJ; McSorley A; Isalska B; Kearns AM; Bright-Thomas R; Brennan AL; Webb AK; Jones AM
    J Cyst Fibros; 2010 Mar; 9(2):104-9. PubMed ID: 20051329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis.
    Stockmann C; Sherwin CM; Zobell JT; Lubsch L; Young DC; Olson J; Noyes BE; Ampofo K; Spigarelli MG
    Pharmacotherapy; 2013 Dec; 33(12):1288-96. PubMed ID: 23824677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of antibiotics for methicillin-resistant Staphylococcus aureus infection in cystic fibrosis.
    Zobell JT; Epps KL; Young DC; Montague M; Olson J; Ampofo K; Chin MJ; Marshall BC; Dasenbrook E
    Pediatr Pulmonol; 2015 Jun; 50(6):552-9. PubMed ID: 25559432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.